Projects per year
Fingerprint
Dive into the research topics where Master Program in Graduate Institute of Cancer Biology and Drug Discovery is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Hsin-Yi Chen
- Master Program in Graduate Institute of Cancer Biology and Drug Discovery - Associate Professor
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery - Joint-Appointment Associate Professor
- TMU Research Center of Cancer Translational Medicine - Member
Person: Researcher
-
Chia-Hsiung Cheng
- Department of Biochemistry and Molecular Cell Biology - Professor
- Master Program in Graduate Institute of Cancer Biology and Drug Discovery - Joint-Appointment Professor
- Taipei Heart Institute (THI), Taipei Medical University - Member
Person: Researcher
-
Kai-Cheng Hsu
- Master Program in Graduate Institute of Cancer Biology and Drug Discovery - Professor
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery - Joint-Appointment Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Professor
- International Ph.D. Program for Translational Science - Joint-Appointment Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Professor
- TMU Research Center of Drug Discovery - Member
- TMU Research Center of Cancer Translational Medicine - Member
Person: Researcher
-
Investigating Potential Biomarkers and Mechanisms of Hdac6 Inhibitors in the Treatment of Human Lung Adenocarcinoma
Pan, S.-L. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Evaluating the Mechanism and Therapeutic Potential of Dyrk1/Clk Inhibitors Modulating Mrna Splicing in Human Digestive Cancers( III )
Pan, S.-L. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Design and Optimization of Novel Dyrk1/Clk Inhibitors Using Artificial Intelligence-Driven and Structure-Based Approaches( III )
Hsu, K.-C. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
Research output
-
A calcium-sensing MCTP1/FYN/MEF2C circuit drives therapy-induced neuroendocrine prostate cancer
Dung, P. V. T., Chen, W. Y., Liu, M. K., Yeh, S. D., Kajla, G., Yeh, H. L., Chen, W. H., Jiang, K. C., Li, H. R., Chen, C. S., Beltran, H., Wen, Y. C. & Liu, Y. N., Jan 2026, In: Neoplasia (United States). 71, 101251.Research output: Contribution to journal › Article › peer-review
Open Access -
Plasmon-activated water reduces amyloid-β42 aggregation and exhibits neuroprotective potential in Alzheimer’s disease
Chiang, C. I., Liu, C. C., Hao, P. J., Chou, C. M., Chu, C. Y., Liu, E. H., Liu, C. Y., Lee, Y. L. A., Hu, C. J., Liu, Y. C. & Cheng, C. H., Apr 2026, In: Journal of the Taiwan Institute of Chemical Engineers. 181, 106507.Research output: Contribution to journal › Article › peer-review
-
2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside–stimulated dental pulp stem cells-derived exosomes for wound healing and bone regeneration
Lin, T. Y., Huang, T. Y., Chiu, H. C., Chung, Y. Y., Lin, W. C., Lin, H. Y. & Lee, S. Y., Jan 2025, In: Journal of Dental Sciences. 20, 1, p. 154-163 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)
Datasets
-
Additional file 1 of Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury
Pan, S.-L. (Contributor), Hsu, K.-C. (Creator), Lin, T. E. (Creator), Lin, C.-F. (Creator), Huang, H.-L. (Contributor) & Huangfu, W.-C. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.11992497.v1, https://doi.org/10.6084%2Fm9.figshare.11992497.v1
Dataset
-
Additional file 5: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chang, L.-H. (Contributor), Liou, J.-P. (Creator), Lai, M.-J. (Contributor), Chang, C.-D. (Contributor), Tu, H.-J. (Contributor), Chao, M.-W. (Contributor), Pan, S.-L. (Contributor), Chen, Y.-Y. (Creator) & Teng, C.-M. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202902.v1, https://doi.org/10.6084%2Fm9.figshare.8202902.v1
Dataset
-
Additional file 4: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M.-W. (Contributor), Chang, L.-H. (Contributor), Tu, H.-J. (Contributor), Chang, C.-D. (Contributor), Lai, M.-J. (Contributor), Chen, Y.-Y. (Creator), Liou, J.-P. (Creator), Teng, C.-M. (Contributor) & Pan, S.-L. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202896.v1, https://springernature.figshare.com/articles/Additional_file_4_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202896/1
Dataset